Predictors of consent to pharmacogenomics testing in the IDEAL study

Pharmacogenomic (PG) testing is important in developing individualized therapeutic approaches. In the phase 3 IDEAL clinical trial, a subset of patients receiving peginterferon and ribavirin for treatment of chronic hepatitis C agreed to provide blood samples for genetic testing. Genome-wide associa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jazwinski, Alison B., Clark, Paul J, Thompson, Alexander J, Gordon, Stuart C., Lawitz, Eric J, Noviello, Stephanie, Brass, Clifford A, Pedicone, Lisa D, Albrecht, Janice K, Sulkowski, Mark S, Muir, Andrew J
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951733/
https://ncbi.nlm.nih.gov/pubmed/24061202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados